Intensity Therapeutics, Inc. (INTS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6K | 0 | 0 | 38.62K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | -38.62K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | 100% | - | - | 100% | 94.03% | - | - | - |
| Operating Expenses | 2.53M | 3.14M | 2.73M | 2.71M | 3.39M | 3.2M | 3.57M | 5.07M | 4.74M | 3.35M | 2.49M | 1.18M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.33M | 1.64M | 1.18M | 1.16M | 1.21M | 1.24M | 1.42M | 1.51M | 1.92M | 1.55M | 1.14M | 323.87K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.2M | 1.5M | 1.55M | 1.54M | 2.19M | 1.97M | 2.15M | 3.56M | 2.81M | 1.8M | 1.35M | 859.21K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.53M | -3.14M | -2.73M | -2.71M | -3.39M | -3.2M | -3.57M | -5.07M | -4.74M | -3.35M | -2.49M | -1.22M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 25.57% | 1.97% | 23.45% | 46.64% | 28.44% | 4.46% | -43.32% | -314.91% | -278.19% | -115.49% | -40.91% | 36.69% |
| EBITDA | -2.53M | -3.14M | 0 | -2.71M | -3.39M | -3.18M | -3.51M | -5.07M | -4.74M | -3.17M | -2.33M | -1.18M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 25.57% | 1.29% | 100% | 46.64% | 28.35% | -0.3% | -50.84% | -328.46% | -310.61% | -115.08% | -32.35% | 37.25% |
| D&A (Non-Cash Add-back) | 0 | 0 | 2.73M | 0 | 0 | 0 | 0 | 0 | 6K | 0 | 0 | 38.62K |
| EBIT | -2.53M | -3.14M | -2.67M | -2.71M | -3.39M | -3.18M | -3.51M | -5.07M | -4.6M | -3.17M | -2.33M | -3.48M |
| Net Interest Income | 94K | 88K | 59K | 17K | 15K | 28K | 48K | 98K | 140K | 175.97K | 147.54K | -222K |
| Interest Income | 94K | 88K | 59K | 17K | 15K | 28K | 48K | 98K | 140K | 175.97K | 147.54K | 171 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 221.78K |
| Other Income/Expense | 92K | 89K | 62K | 168K | 47K | 22K | 57K | 98K | 140K | 181.41K | 162K | -2.48M |
| Pretax Income | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.7M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.7M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 27.28% | 4.09% | 23.97% | 48.96% | 27.29% | -0.31% | -50.84% | -34.33% | -244.41% | -109.97% | -31.22% | -91.97% |
| Net Income (Continuing) | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.96 | -1.21 | -1.55 | -3.25 | -5.50 | -5.50 | -6.25 | -9.00 | -8.50 | -5.75 | -4.25 | -35.75 |
| EPS Growth % | 82.55% | 78% | 75.2% | 63.89% | 35.29% | 4.35% | -47.06% | 74.83% | 12.82% | 47.73% | 67.31% | -150.88% |
| EPS (Basic) | -0.96 | -1.21 | -1.55 | -3.25 | -5.50 | -5.50 | -6.25 | -9.00 | -8.50 | -5.75 | -4.25 | -35.75 |
| Diluted Shares Outstanding | 25.34M | 13.56M | 1.72M | 754.73K | 606.93K | 576.04K | 552.19K | 548.49K | 548.38K | 550.61K | 546.42K | 140.66K |
| Basic Shares Outstanding | 25.34M | 13.56M | 1.72M | 754.72K | 606.92K | 576K | 552.16K | 548.48K | 548.36K | 550.6K | 546.4K | 103.6K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |